February 15, 2024 · Form 4 insider transaction
Gravier Pierre bought 19,000 shares of PTC Therapeutics Inc at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Restricted stock units granted on February 15, 2024 that vest in four equal installments over four years, commencing on February 15, 2025.